All News

2019

April

Media Release / Apr 30, 2019

Sandoz enters agreement for proposed trastuzumab biosimilar, currently in Phase III development, to treat selected HER2-positive cancer tumors

Read More
Media Release / Apr 24, 2019

Novartis starts 2019 with strong sales and double digit core[1] operating income growth, Mayzent launch and Alcon spin-off; profit guidance upgraded

Read More
Media Release / Apr 11, 2019

Sandoz drives differentiated portfolio with deal to commercialize new treatment for Opioid-Induced Constipation in key European countries

Read More
Media Release / Apr 02, 2019

Sandoz resubmits biosimilar pegfilgrastim application to US FDA

Read More

March

Media Release / Mar 14, 2019

Novartis announces change in Sandoz leadership

Read More
Media Release / Mar 10, 2019

Three winners of 2019 Sandoz Healthcare Access Challenge (HACk) are announced at SXSW

Read More

January

Media Release / Jan 31, 2019

Sandoz certified Global Top Employer 2019

Read More
Media Release / Jan 30, 2019

Novartis delivered strong sales growth with core margin expansion, built leading advanced therapy platforms and focused the company in 2018

Read More
Media Release / Jan 16, 2019

Sandoz Inc. launches SYMJEPI™ (epinephrine) in the US

Read More
Media Release / Jan 16, 2019

Sandoz selects three finalists for Healthcare Access Challenge (Sandoz HACk) from over 400 global entries

Read More